Biostem Technologies Inc. logo

Biostem Technologies Inc. (BSEM)

Market Closed
21 Sep, 19:59
OTC PINK OTC PINK
$
4. 44
-0.3
-6.3291%
$
80.5M Market Cap
- P/E Ratio
- Div Yield
218,540 Volume
- Eps
$ 4.74
Previous Close
Add Transaction
Day Range
4.44 5.25
Year Range
2.25 8.4
Want to track BSEM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BSEM closed today lower at $4.44, a decrease of -6.3291% from yesterday's close, completing a monthly increase of 20.6522% or $0.76. Over the past 12 months, BSEM stock gained 16.8421%.
BSEM is not paying dividends to its shareholders.
The last earnings report, released on Apr 06, 2026, missed the consensus estimates by -0.02%. On average, the company has fell short of earnings expectations by -0.5063%, based on the last three reports.
Biostem Technologies Inc. has completed 7 stock splits, with the recent split occurring on Jan 27, 2015.
The company's stock is traded on one exchange.

BSEM Chart

People also search for

Northwest Biotherapeutics Inc.
$ 0.17
+4.75%
Cyberdyne Inc. Sponsored ADR
$ 1.51
-1.8182%
Implanet S.A. Sponsored ADR
$ 0.08
0%
HighTide Therapeutics, Inc.
$ 0.39
0%
BICO Group AB ADR
$ 0.59
0%
BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal

BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal

BioStem Technologies OTCMKTS: BSEM outlined its strategy to expand in surgical applications, shift its revenue mix away from physician-office wound care and bring manufacturing of acquired products into its Florida facility.

Marketbeat | 1 month ago
BioStem Technologies Q2 Earnings Call Highlights

BioStem Technologies Q2 Earnings Call Highlights

BioStem Technologies OTCMKTS: BSEM reported second-quarter revenue of $7.9 million as the company continued its transition to a predominantly hospital-focused commercial model. Revenue increased from $6.1 million in the first quarter, supported by higher hospital sales, expanded commercial coverage and a full quarter of contribution from its acquired business.

Marketbeat | 1 month ago
BioStem Technologies, Inc. (BSEM) Q2 2026 Earnings Call Transcript

BioStem Technologies, Inc. (BSEM) Q2 2026 Earnings Call Transcript

BioStem Technologies, Inc. (BSEM) Q2 2026 Earnings Call Transcript

Seekingalpha | 1 month ago

Biostem Technologies Inc. (BSEM) FAQ

What is the stock price today?

The current price is $4.44.

On which exchange is it traded?

Biostem Technologies Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is BSEM.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 80.5M.

Has Biostem Technologies Inc. ever had a stock split?

Biostem Technologies Inc. had 7 splits and the recent split was on Jan 27, 2015.

Biostem Technologies Inc. Profile

Biotechnology Industry
Healthcare Sector
Jason Matuszewski CEO
OTC PINK Exchange
090684200 CUSIP
US Country
73 Employees
- Last Dividend
27 Jan 2015 Last Split
- IPO Date

Overview

BioStem Technologies, Inc. is a pioneering life sciences corporation with a core focus on the discovery, development, and production of pharmaceutical and regenerative medicine products and services. Established in 2006, the company has positioned itself at the forefront of biologic stem cell-based alternatives aimed at treating a wide array of ailments, ranging from joint pain and neurodegenerative disorders to tendon, ligament injuries, and autoimmune diseases. Apart from its therapeutic innovations, BioStem Technologies extends its expertise to the repackaging and distribution of active pharmaceutical ingredients along with other essential supplies for pharmaceutical compounding. With its headquarters nestled in Pompano Beach, Florida, the company effectively harnesses e-commerce platforms to market and sell its diverse product lineup, both domestically and internationally. Progressing towards its mission, BioStem Technologies continues to forge new paths in the life sciences sector, striving to improve patient outcomes through its cutting-edge products and services.

Products and Services

  • Biologic Stem Cell Based Alternative Products
  • At the heart of BioStem Technologies' product offerings are its biologic stem cell based alternatives designed to treat various ailments. These innovative treatments are developed as part of the company's commitment to regenerative medicine, targeting conditions such as joint pain, tendon and ligament injuries, as well as neurodegenerative and autoimmune diseases. Through extensive research and development, these products aim to offer effective solutions by harnessing the natural healing power of stem cells.

  • Repackaging and Distribution of Active Pharmaceutical Ingredients
  • BioStem Technologies also specializes in the repackaging and distribution of active pharmaceutical ingredients (APIs) and other necessary supplies for pharmaceutical compounding. This service caters to the broader needs of the pharmaceutical sector by ensuring the availability of high-quality ingredients and supplies essential for the creation of compounded medications, thereby supporting bespoke treatment options for patients.

  • Nutraceutical Products under Dr. Dave's Best and Nesvik Organics Brands
  • The company has expanded its product range to include nutraceutical products marketed under the Dr. Dave's Best and Nesvik Organics brands. These offerings are part of BioStem Technologies' venture into the health and wellness segment, providing consumers with dietary supplements and organic products. Manufactured with an emphasis on quality and efficacy, these nutraceuticals aim to support overall health and complement the therapeutic benefits of the company's regenerative medicine products.

  • Non-proprietary Products
  • In addition to branded products, BioStem Technologies develops and markets a range of non-proprietary products. These offerings serve to broaden the company's market reach, catering to diverse consumer needs in the realm of pharmaceuticals and regenerative medicine. The non-proprietary product lineup is designed with the same commitment to quality and innovation that characterizes all of BioStem Technologies' solutions, ensuring a wide array of options for healthcare providers and patients alike.

Contact Information

Address: 4901 Northwest 17th Way
Phone: 954 380 8342